Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
viral vectors
Pharma
FDA probes Novartis’ Zolgensma gene therapy over cancer risks
The FDA also flagged two recent reports of other gene therapy candidates where AAV vector integration drove tumor formation.
Angus Liu
Nov 9, 2026 11:14am
VintaBio assets for sale as CGT production sector slows
Nov 5, 2026 9:55am
Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business
Nov 3, 2026 9:21am
With ‘lessons learned,’ Kite preps for key CAR-T launch
Apr 28, 2026 11:30am
OXB expands BMS partnership for CAR-T lentiviral vectors
Feb 4, 2026 10:25am
FDA restricts bluebird's gene therapy after blood cancer reports
Aug 8, 2025 11:19am